Expertise in

conditions

Holger D. Thiele

Kerpener Str 62,

Koeln, NW, DE

Expertise in

conditions

Kerpener Str 62,

Koeln, NW, DE

Overview

Holger Thiele practices practicing medicine in Koeln, Germany.

Mr. Thiele is highly rated in 82 conditions, according to our data. His clinical expertise encompasses Heart Attack, Cardiogenic Shock, Tricuspid Regurgitation, Percutaneous Coronary Intervention (PCI), and Transcatheter Aortic Valve Replacement (TAVR).

He is actively involved in clinical research, co-authoring 1326 peer reviewed articles and participating in 9 clinical trials.

Gender

Male

Locations

Kerpener Str 62, Koeln, NW 50937, Germany

Other Locations

St. Josef Hospital, Bochum, NW, Germany

Strümpel Str. 39, Leipzig, SN 04289, Germany

Ratzeburger Allee 160, Luebeck, SH, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation

Enrollment Status: Active_not_recruiting

Publish Date: April 09, 2026

Intervention Type: Device

Study Phase: Not Applicable

Prospective RandomizEd Study Comparing Glycoprotein IIb/IIIa Inhibitors VERsus Standard Therapy in PatientS with Myocardial Infarction and Angiographic Evidence of No-reFLOW

Enrollment Status: Active_not_recruiting

Publish Date: January 03, 2025

Intervention Type: Drug

Study Drug: Glycoprotein IIb/IIIa Inhibitors

Study Phase: Phase 4

HighLife™ Transcatheter Mitral Valve Replacement System for Severe Mitral Regurgitation in Patients at High Surgical Risk

Enrollment Status: Completed

Publish Date: October 03, 2024

Intervention Type: Device

Study Phase: Not Applicable

Randomized, Multi-Center, Event-Driven Trial of TAVI Versus SAVR in Patients With Symptomatic Severe Aortic Valve Stenosis and Intermediate Risk of Mortality, as Assessed by STS-Score - DEDICATE

Enrollment Status: Active_not_recruiting

Publish Date: April 26, 2024

Intervention Type: Device, Procedure

Study Phase: Not Applicable

CompariSon of secOnd-generation seLf-expandable Versus Balloon-expandable Valves and gEneral Versus Local Anesthesia in Transcatheter Aortic Valve Implantation (SOLVE-TAVI)

Enrollment Status: Unknown

Publish Date: February 18, 2021

Intervention Type: Device, Procedure

Study Phase: Not Applicable

EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus

Enrollment Status: Terminated

Publish Date: September 26, 2019

Intervention Type: Device

Study Phase: Not Applicable

Everolimus-eluting Bioresorbable Vascular Scaffolds Versus Everolimus-eluting Stents in Patients With Chronic Total Occlusion

Enrollment Status: Terminated

Publish Date: September 26, 2019

Intervention Type: Device

Study Phase: Not Applicable

Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial Infarction

Enrollment Status: Completed

Publish Date: August 08, 2019

Intervention Type: Drug

Study Phase: Phase 4

Prospective Randomized Multicenter Study Comparing Immediate Multivessel Revascularization by PCI Versus Culprit Lesion PCI With Staged Non-culprit Lesion Revascularization in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock

Enrollment Status: Completed

Publish Date: November 09, 2017

Intervention Type: Procedure

Study Phase: Phase 4

View 8 Less Clinical Trials

1325 Total Publications

Preventing Complications of Mechanical Circulatory Support Devices: The Clue for Improved Outcomes?

Journal: Circulation. Cardiovascular interventions

Published: March 29, 2026

View All 1325 Publications

Frequently Asked Questions about Holger D. Thiele

Is Holger D. Thiele a top-rated expert for Heart Attack?

MediFind is an objective health platform that identifies experts based on real-world data. Holger D. Thiele is classified as an Elite expert for Heart Attack, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Holger D. Thiele participate in research or clinical trials?

Yes. Holger D. Thiele has published 1325 articles and abstracts on conditions like Heart Attack. You can view a list of Holger D. Thiele's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Thiele's expertise for a condition

ConditionClose